Houston, Texas — According to state and local economic development sources NuProbe plans to invest $1,000,000.00 to build out 4,700 square feet of new space in Houston. The company plans to occupy the new space at 8965 Interchange Drive in Houston, on or about March 1, 2023. According to the company website NuProbe takes a multi-platform approach to apply its breakthrough technologies in genomics research to enable diseases to be detected, treated, and cured at early stages for better outcomes with lower costs. Founded in 2016 and building on scientific findings licensed from the Wyss Institute at Harvard and Rice University, NuProbe is a privately held company with facilities in the US (Houston, TX) and China (Shanghai). The company has assembled an executive team of industry veterans, world-renowned scientists, and entrepreneurs.

To learn more about NuProbe, visit http://www.nuprobe.com/

Company Contact:
David Yu-Zhang, Chief Executive Officer
713-485-0148

SOURCE: http://www.intelligence360.io
Copyright (c) 2022 SI360 Inc. All rights reserved